7-methoxy-3-methyl-2-(2-(4-(trifluoromethoxy)phenyl)pyridin-4-yl)quinolin-4(1H)-one

ID: ALA3740357

Chembl Id: CHEMBL3740357

PubChem CID: 127038423

Max Phase: Preclinical

Molecular Formula: C23H17F3N2O3

Molecular Weight: 426.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(=O)c(C)c(-c3ccnc(-c4ccc(OC(F)(F)F)cc4)c3)[nH]c2c1

Standard InChI:  InChI=1S/C23H17F3N2O3/c1-13-21(28-20-12-17(30-2)7-8-18(20)22(13)29)15-9-10-27-19(11-15)14-3-5-16(6-4-14)31-23(24,25)26/h3-12H,1-2H3,(H,28,29)

Standard InChI Key:  GDNWFIQEVYBGSD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3740357

    ---

Associated Targets(Human)

MAT2A Tchem S-adenosylmethionine synthase isoform type-2 (713 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

URA1 Dihydroorotate dehydrogenase (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.39Molecular Weight (Monoisotopic): 426.1191AlogP: 5.47#Rotatable Bonds: 4
Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.42CX LogP: 5.73CX LogD: 5.73
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.47Np Likeness Score: -0.58

References

1. Charoensutthivarakul S, David Hong W, Leung SC, Gibbons PD, Bedingfield PTP, Nixon GL, Lawrenson AS, Berry NG, Ward SA, Biagini GA, O'Neill PM.  (2015)  2-Pyridylquinoloneantimalarials with improved antimalarial activity and physicochemical properties,  (7): [10.1039/C5MD00062A]
2. Lin H,Luengo JI.  (2020)  Exploiting binding-site arginines in drug design: Recent examples.,  30  (19.0): [PMID:32730944] [10.1016/j.bmcl.2020.127442]

Source